Latest in Resource Center: Type 2 Diabetes

Reuters Health • The Doctor's Channel Daily Newscast

Value of early, intensive diabetes treatment questionable

NEW YORK (Reuters Health) – Intensive treatment of type 2 diabetes that’s detected early through screening does not seem to reduce rates of subsequent complications, a Danish study indicates. “We found no statistically significant effect of intensive multifactorial treatment on the prevalence of...

Reuters Health • The Doctor's Channel Daily Newscast

Add-on dapagliflozin improves diabetes control without weight gain

NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss, according to the results of a trial reported in Diabetes Care online August 4. “Dapagliflozin is a...

Reuters Health • The Doctor's Channel Daily Newscast

Metformin improves outcomes in diabetics with hepatitis C cirrhosis

NEW YORK (Reuters Health) – Patients with type 2 diabetes who also have liver cirrhosis associated with hepatitis C virus (HCV) infection fare significantly better when they’re treated with metformin, results of a French study indicate. “We found that metformin treatment was independently associated...

Glycemic Control in Childhood T2DM